Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • COMMENT

Long COVID research risks losing momentum – we need a moonshot

People protest demanding action on chronic fatigue syndrome and long COVID-19 in front of the White House

Protesters outside the White House in Washington DC demand action on long COVID. Credit: Zeynep Tufekci/New York Times/Redux/eyevine

You have full access to this article via your institution.

Enjoying our latest content?
Login or create an account to continue

  • Access the most recent journalism from Nature's award-winning team
  • Explore the latest features & opinion covering groundbreaking research

or

Nature 622, 457-460 (2023)

doi: https://doi.org/10.1038/d41586-023-03225-w

References

  1. Callard, F. & Perego, E. Soc. Sci. Med. 268, 113426 (2021).

    Article  PubMed  Google Scholar 

  2. Robertson, M. M. et al. Clin. Infect. Dis. 76, 1636–1645 (2023).

    Article  PubMed  Google Scholar 

  3. Davis, H. E., McCorkell, L., Vogel, J. M. & Topol, E. J. Nature Rev. Microbiol. 21, 133–146 (2023).

    Article  PubMed  Google Scholar 

  4. Cutler, D. M. JAMA Health Forum 3, e221809 (2022).

    Article  PubMed  Google Scholar 

  5. Choutka, J., Jansari, V., Hornig, M. & Iwasaki, A. Nature Med. 28, 911–923 (2022).

    Article  PubMed  Google Scholar 

  6. Institute of Medicine. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness (National Academies Press, 2015).

    Google Scholar 

  7. DeLong, A., Hsu, M. & Kotsoris, H. BMC Public Health 19, 352 (2019).

    Article  PubMed  Google Scholar 

  8. Wohl, D. A. et al. Clin. Infect. Dis. 76, e835–e840 (2023).

    Article  PubMed  Google Scholar 

  9. Litleskare, S. et al. Clin. Gastroenterol. Hepatol. 16, 1064–1072 (2018).

    Article  PubMed  Google Scholar 

  10. Peluso, M. J. et al. Open Forum Infect. Dis. 9, ofab640 (2022).

    Article  PubMed  Google Scholar 

  11. Schultheiß, C. et al. Cell Rep. Med. 3, 100663 (2022).

    Article  PubMed  Google Scholar 

  12. Peluso, M. J. et al. Preprint at medRxiv https://doi.org/10.1101/2023.07.27.23293177 (2023).

  13. Proal, A. D. et al. Nature Immunol. 24, 1616–1627 (2023).

    Article  PubMed  Google Scholar 

  14. Durstenfeld, M. S. et al. JAMA Netw. Open 5, e2236057 (2022).

    Article  PubMed  Google Scholar 

  15. Klein, J. et al. Nature https://doi.org/10.1038/s41586-023-06651-y (2023).

    Article  Google Scholar 

  16. Lancet Infect. Dis. 23, 879 (2023).

    Article  PubMed  Google Scholar 

  17. Subbiah, V. Nature Med. 29, 49–58 (2023).

    Article  PubMed  Google Scholar 

  18. Gewandter, J. S. et al. Pain 155, 1683–1695 (2014).

    Article  PubMed  Google Scholar 

  19. Subramanian, A. et al. Nature Med. 28, 1706–1714 (2022).

    Article  PubMed  Google Scholar 

Download references

Competing Interests

M.J.P. declares the following: consultation fees for Gilead Sciences and AstraZeneca in the last 2 years; Data Safety Monitoring Board membership for American Gene Technologies.

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links